Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. Am J Nephrol. 2016; 44(4):316-325.

View in: PubMed

subject areas

24,25-Dihydroxyvitamin D 3
Aged
Calcifediol
Calcium
Creatinine
Delayed-Action Preparations
Double-Blind Method
Female
Fibroblast Growth Factors
Glomerular Filtration Rate
Humans
Hyperparathyroidism
Male
Middle Aged
Parathyroid Hormone
Phosphorus
Renal Insufficiency, Chronic
Vitamin D
Vitamin D Deficiency
Vitamins

authors with profiles

Stuart M. Sprague